Gb Sciences' First-in-Class Parkinson's Disease Therapy Successfully Completes Dose Response Study a
The Parkinson's disease market is expected to grow to $12.8 billion by 2028. Brain Parkinsons Study LAS VEGAS, July 11, 2023 (Newswire.com) - Gb Sciences, Inc. (OTCQB:GBLX), a leading cannabis- and plant...
Robert Sutherland Neurocage Systems Ltd Board Of Governors Research Michigan State University Gb Sciences University Of Lethbridge
Source: pharmiweb.com